SRL Medisearch   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Osaka Japan (1918)

Organization Overview

First Clinical Trial
2010
NCT01101035
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

SRL Medisearch Inc. | SRL Mediserch.Inc | Teijin America, Inc. | Teijin Pharma

Active Ingredients

Drugs in Phase 3 Trials (5)

allopurinol (zyloprim) (1 trial)

febuxostat (uloric) (2 trials)

fluticasone (cutivate) (1 trial)

umeclidinium (incruse ellipta) (1 trial)

vilanterol (Anoro Elipta) (1 trial)

Drugs in Phase 2 Trials (2)

ktp-001 (1 trial)

tmx-049 (1 trial)

Drugs in Phase 1 Trials (1)

pirfenidone (esbriet) (1 trial)

Drugs in Other Trials (1)

mirogabalin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Albuminuria (Phase 2)

Asthma (Phase 3)

Cardiovascular Diseases (Phase 3)

Diabetic Nephropathies (Phase 2)

Hernia (Phase 2)

Kidney Diseases (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 9